{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:27:39Z","timestamp":1790684859081,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dr. Marina Frusic-Zlotkin"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jconrel.2015.09.012","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T18:21:24Z","timestamp":1442254884000},"page":"202-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach"],"prefix":"10.1016","volume":"217","author":[{"given":"Liat","family":"Soudry-Kochavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Naraykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Benita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.09.012_bb0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0958-1669(00)00202-0","article-title":"Emerging protein delivery methods","volume":"12","author":"Cleland","year":"2001","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0010","series-title":"Biotechnology and Biopharmaceuticals","first-page":"339","article-title":"Advanced drug delivery","author":"Ho","year":"2003"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0020","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","article-title":"Is the oral route possible for peptide and protein drug delivery?","volume":"11","author":"Morishita","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejps.2006.05.008","article-title":"Preparing and evaluating delivery systems for proteins","volume":"29","author":"Jorgensen","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejpb.2007.07.013","article-title":"Approval of new biopharmaceuticals 1999\u20132006: comparison of the US, EU and Japan situations","volume":"68","author":"Tsuji","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.copbio.2003.10.007","article-title":"Drug delivery in biotechnology: present and future","volume":"14","author":"Orive","year":"2003","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00063030-200519030-00003","article-title":"Oral delivery of peptide drugs: barriers and developments","volume":"19","author":"Hamman","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejpb.2008.09.003","article-title":"Lipid nanoparticles for parenteral delivery of actives","volume":"71","author":"Joshi","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.supflu.2008.10.005","article-title":"Rational design of drug\u2013polymer co-formulations by CO2 anti-solvent precipitation","volume":"48","author":"Kluge","year":"2009","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopha.2004.02.001","article-title":"Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs","volume":"58","author":"Gursoy","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0065","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.addr.2007.04.007","article-title":"Solid lipid nanoparticles as a drug delivery system for peptides and proteins","volume":"59","author":"Almeida","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejpb.2004.10.006","article-title":"Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles","volume":"59","author":"Bilati","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2007.09.013","article-title":"Nano\/microtechnologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives","volume":"125","author":"Mundargi","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0080","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1177\/193229681000400629","article-title":"Novel glucagon-like peptide-1 analog delivered orally reduces postprandial glucose excursions in porcine and canine models","volume":"4","author":"Eldor","year":"2010","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0085","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.biomaterials.2010.12.044","article-title":"The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo","volume":"32","author":"Nguyen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0090","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from heloderma suspectum venom","volume":"267","author":"Eng","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0095","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrd1828","article-title":"Exenatide","volume":"4","author":"Davidson","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijpharm.2008.01.015","article-title":"Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration","volume":"356","author":"Gedulin","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0105","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0142-9612(99)00002-2","article-title":"Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro","volume":"20","author":"Tracy","year":"1999","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0110","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","article-title":"Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. For the DURATION-1 study group","volume":"372","author":"Drucker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.regpep.2008.07.003","article-title":"Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes","volume":"151","author":"Linnebjerg","year":"2008","journal-title":"Regul. Pept."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-5173(99)00370-1","article-title":"Desolvation process and surface characterization of protein nanoparticles","volume":"194","author":"Weber","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0125","first-page":"293","article-title":"Effect of replacement fluids saline, gelofusine, and blood on biochemical and hematological parameters in rats subjected to repeated blood sampling","volume":"15","author":"Skrajnar","year":"2009","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.jconrel.2015.09.012_bb0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/bit.10025","article-title":"Water-based nanoparticulate polymeric system for protein delivery: permeability control and vaccine application","volume":"75","author":"Prokop","year":"2001","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0135","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1039\/C1CS15239D","article-title":"Polysaccharides as building blocks for nanotherapeutics","volume":"41","author":"Mizrahy","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02976496","article-title":"Albumin release from biodegradable hydrogels composed of dextran and poly(ethylene glycol) macromer","volume":"24","author":"Kim","year":"2001","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0145","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1021\/ma00122a044","article-title":"Synthesis, characterization and polymerization of glycidyl methacrylate derivatized dextran","volume":"28","author":"van Dijk-Wolthuis","year":"1995","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/JB.71.3.373-380.1956","article-title":"Degradation of dextrans by enzymes of intestinal bacteria","volume":"71","author":"Sery","year":"1956","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.carbpol.2008.03.005","article-title":"Preparation of crosslinked starch microspheres and their drug loading and releasing properties","volume":"74","author":"Yuan-yuan","year":"2008","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0160","first-page":"3405","article-title":"pH-sensitive degradable nanoparticles for highly efficient intracellular delivery of exogenous protein","volume":"8","author":"Xu","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0165","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1021\/jf404621f","article-title":"Fabrication of self-assembled (\u2212)-epigallocatechin gallate (EGCG) ovalbumin\u2212dextran conjugate nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells","volume":"62","author":"Li","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2008.08.021","article-title":"Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug","volume":"133","author":"Nassar","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0175","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1023\/A:1012035113276","article-title":"Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery","volume":"14","author":"Chan","year":"1997","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2015.09.012_bb0180","article-title":"Oral delivery of exenatide microspheres prepared by cross-linking of alginate and hyaluronate","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0185","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biomaterials.2011.10.075","article-title":"Goblet cell targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport","volume":"33","author":"Jin","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.09.012_bb0190","article-title":"The glucose-lowering potential of exenatide delivered orally via goblet cell- targeting nanoparticles","author":"Li","year":"2014","journal-title":"Pharm. Res."},{"issue":"43","key":"10.1016\/j.jconrel.2015.09.012_bb0195","doi-asserted-by":"crossref","first-page":"17498","DOI":"10.1073\/pnas.1313839110","article-title":"Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption","volume":"110","author":"Attili-Qadria","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2015.09.012_bb0200","first-page":"2505","article-title":"Enhanced lymphatic delivery of mitomycin C conjugated with dextran","volume":"44","author":"Takakura","year":"1984","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2015.09.012_bb0205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.18433\/J3N590","article-title":"Targeting the c-type lectins-mediated host-pathogen interactions with dextran","volume":"17","author":"Pustylnikov","year":"2014","journal-title":"J. Pharm. PharmSci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915301140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915301140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T03:32:07Z","timestamp":1718076727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915301140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":41,"alternative-id":["S0168365915301140"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.012","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}